zoledronic acid has been researched along with B16 Melanoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedida-Metula, S; Fishman, D; Koshelev, V; Kushnir, P; Levin-Gromiko, U; Voronov, E | 1 |
| Cho, HI; Kim, TG; Park, HM; Shin, CA; Shon, HJ | 1 |
| Babu, R; Chen, L; Ding, Y; Liu, X; Ravis, W; Wang, Y; Yan, W | 1 |
| Ahn, GO; Brown, JM | 1 |
4 other study(ies) available for zoledronic acid and B16 Melanoma
| Article | Year |
|---|---|
Amplified lipid rafts of malignant cells constitute a target for inhibition of aberrantly active NFAT and melanoma tumor growth by the aminobisphosphonate zoledronic acid.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Cholesterol; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Melanoma, Experimental; Membrane Microdomains; Mice; NFATC Transcription Factors; Signal Transduction; Zoledronic Acid | 2014 |
Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine.
Topics: Animals; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Diphosphonates; Female; Imidazoles; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Poly I-C; Spleen; Vaccines, Subunit; Zoledronic Acid | 2016 |
Codelivery of zoledronic acid and doublestranded RNA from core-shell nanoparticles.
Topics: Animals; Cell Line, Tumor; Cell Survival; Diphosphonates; Drug Stability; Female; Imidazoles; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Poly I-C; Random Allocation; RNA, Double-Stranded; Zoledronic Acid | 2013 |
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Transplantation; CD11b Antigen; Diphosphonates; Endothelial Cells; Imidazoles; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myeloid Cells; Neoplasms, Experimental; Neovascularization, Pathologic; Protease Inhibitors; Signal Transduction; Stem Cells; Subcutaneous Tissue; Time Factors; Zoledronic Acid | 2008 |